02/22/2024

Congress Seeks to Finish FY 2024 Funding with Start of FY 2025 Budget Process on Horizon

The federal government is currently operating under a temporary spending measure, or continuing resolution (CR), that will keep the government open while Congress continues its negotiations on a final fiscal year (FY) 2024 budget. Like the prior CR passed in November 2023, the current law sets up two staggered deadlines, with funding for some federal agencies, including the Food and Drug Administration (FDA), expiring on March 1, while funding for other agencies – including the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) – running through March 8. 

Meanwhile, even as final FY 2024 spending remains in question, congressional leaders are preparing for the start of the FY 2025 budget process. President Biden recently announced that his FY 2025 budget proposal will be released March 11, days after his State of the Union address on March 7. The President’s budget proposal kicks off the annual appropriations process and outlines the administration’s priorities for the coming fiscal year. ASH will provide updates on the budget proposal’s provisions impacting hematology research and practice after it has been released. 

ASH will continue to advocate with other members of the research and public health communities for the highest possible levels of federal funding for biomedical research and public health programs in FY 2024 and beyond. Grassroots support is critical to show your elected officials the importance of sustained and predictable public health funding. Visit the ASH Advocacy Center, enter your contact information, and click “Submit Email” to quickly and easily send a message to your elected officials about the importance of NIH, CDC, and other federal health programs.